RXO Inc: BMO cuts to market perform from outperform; cuts target price to $30.25 from $35
RXO•BMO downgraded RXO to market perform from outperform and lowered its target price to $30.25 from $35.
Related News
Nexstar Media Group schedules quarterly results conference call and webcast
NXST•
Zapata Quantum joins IBM Quantum Network for quantum application development
ZPTA•
Humana report pegs Kentucky economic output impact at $19.9 billion in 2025
HUM•
Contango Silver & Gold intersects 140.23 g/t gold over 0.63 meters at Lucky Shot project in Alaska
CTGO•
BridgeBio rises on FDA priority review for dwarfism drug
BBIO•